Exact Mass: 1050.4341374

Exact Mass Matches: 1050.4341374

Found 16 metabolites which its exact mass value is equals to given mass value 1050.4341374, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PIP3(16:0/16:0)

{[(3s,5S)-3-({[(2R)-2,3-bis(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4-dihydroxy-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid

C41H82O22P4 (1050.4247992)


PIP3(16:0/16:0) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(16:0/16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol. [HMDB] PIP3(16:0/16:0) is a phosphatidylinositol trisphosphate. Phosphatidylinositol trisphosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a trisphosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol trisphosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositols trisphosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 18 and 20 carbons are the most common. PIP3(16:0/16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. The most important phosphatidylinositol trisphosphate in both quantitative and biological terms is phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signalling molecules, via the action of phospholipase C enzymes. Phosphatidylinositols phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   
   

PIP3(32:0)

1,2-Dihexadecanoyl-rac-glycero-3-phospho-(1-myo-inositol-3,4,5-trisphosphate)

C41H82O22P4 (1050.4247992)


   

PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl)

1-(1,2R-dihexadecanoylphosphatidyl)inositol-3,4,5-trisphosphate, tetrasodium salt

C41H82O22P4 (1050.4247992)


   

1,2-dihexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate)

1,2-dihexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate)

C41H82O22P4 (1050.4247992)


A 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as hexadecanoyl (palmitoyl).

   

Phosphatidylinositol triphosphate(32:0)

Phosphatidylinositol triphosphate(32:0)

C41H82O22P4 (1050.4247992)


   
   
   
   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2r)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2r)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

C46H71BrN10O13 (1050.4385176)


   

5-{[(1e)-3-[(4-carboxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butyl)amino]-5-({[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}methyl)-5-hydroxy-2-methoxycyclohex-3-en-1-ylidene]amino}-2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

5-{[(1e)-3-[(4-carboxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butyl)amino]-5-({[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}methyl)-5-hydroxy-2-methoxycyclohex-3-en-1-ylidene]amino}-2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C45H70N4O24 (1050.437978)


   

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-5-[(3-bromo-4-methoxyphenyl)methyl]-2-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

C46H71BrN10O13 (1050.4385176)


   

5-({3-[(4-carboxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butyl)amino]-5-({[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}methyl)-5-hydroxy-2-methoxycyclohex-3-en-1-ylidene}amino)-2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

5-({3-[(4-carboxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butyl)amino]-5-({[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}methyl)-5-hydroxy-2-methoxycyclohex-3-en-1-ylidene}amino)-2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C45H70N4O24 (1050.437978)


   

n-{5-[(3-bromo-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

n-{5-[(3-bromo-4-methoxyphenyl)methyl]-6,13,16,21-tetrahydroxy-15-[3-(c-hydroxycarbonimidoylamino)propyl]-8-isopropyl-4,11-dimethyl-3,9,22-trioxo-2-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl}-2-[(1-hydroxybutylidene)amino]pentanediimidic acid

C46H71BrN10O13 (1050.4385176)


   

[(3s,4r,5r,6r)-5-{[(2s,3s,4r,5r,6s)-5-{[(2s,3r,4r,5r,6s)-4-{[(2r,3r,4s,5r)-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-{[(1r,4s,5s,8r,10r,14r,16r,19s)-5,9,9,14-tetramethyl-18-oxo-19-(prop-1-en-2-yl)-17-oxapentacyclo[14.2.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰]nonadec-12-en-8-yl]oxy}oxan-3-yl]oxidanesulfonic acid

[(3s,4r,5r,6r)-5-{[(2s,3s,4r,5r,6s)-5-{[(2s,3r,4r,5r,6s)-4-{[(2r,3r,4s,5r)-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-{[(1r,4s,5s,8r,10r,14r,16r,19s)-5,9,9,14-tetramethyl-18-oxo-19-(prop-1-en-2-yl)-17-oxapentacyclo[14.2.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰]nonadec-12-en-8-yl]oxy}oxan-3-yl]oxidanesulfonic acid

C48H74O23S (1050.4341374)